Dr. Edmund Bartlett, MD
Claim this profileMemorial Sloan Kettering Cancer Centre
Area of expertise
Soft Tissue Sarcoma
Edmund Bartlett, MD has run 2 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Dermatofibrosarcoma Protuberans
Edmund Bartlett, MD has run 1 trial for Dermatofibrosarcoma Protuberans. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Centre
Memorial Sloan Kettering Cancer Center
Clinical Trials Edmund Bartlett, MD is currently running
Intratumoral Tigilanol Tiglate
for Soft Tissue Sarcoma
A Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol tiglate in advanced and/or metastatic soft tissue sarcoma of the extremities and body wall.
Recruiting
1 award
Phase 2
Pembrolizumab + Local Chemotherapy
for Sarcoma
The purpose of this study is to find out whether giving the study drug pembrolizumab in combination with the chemotherapy drugs melphalan and dactinomycin, delivered directly to the affected arm or leg using a technique called isolated limb infusion (ILI), is a safe treatment that can delay the time before your disease gets worse (progresses).
Recruiting
3 awards
Phase 2
12 criteria
More about Edmund Bartlett, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Edmund Bartlett, MD has experience with
- Dactinomycin
- Isolated Limb Infusion
- Melphalan
- Pembrolizumab
- Tigilanol Tiglate
Breakdown of trials Edmund Bartlett, MD has run
Soft Tissue Sarcoma
Dermatofibrosarcoma Protuberans
Alveolar Soft Part Sarcoma
Soft tissue sarcoma
Malignant Fibrous Histiocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edmund Bartlett, MD specialize in?
Edmund Bartlett, MD focuses on Soft Tissue Sarcoma and Dermatofibrosarcoma Protuberans. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Edmund Bartlett, MD currently recruiting for clinical trials?
Yes, Edmund Bartlett, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Edmund Bartlett, MD has studied deeply?
Yes, Edmund Bartlett, MD has studied treatments such as Dactinomycin, Isolated Limb Infusion, Melphalan.
What is the best way to schedule an appointment with Edmund Bartlett, MD?
Apply for one of the trials that Edmund Bartlett, MD is conducting.
What is the office address of Edmund Bartlett, MD?
The office of Edmund Bartlett, MD is located at: Memorial Sloan Kettering Cancer Centre, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.